Report Detail
Global Measles Combined with Live Attenuated Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4624503 |
- 10 September, 2025 |
- Global |
- 78 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Measles Combined with Live Attenuated Vaccine market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Measles Combined with Live Attenuated Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Measles Combined with Live Attenuated Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Measles Combined with Live Attenuated Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Measles Combined with Live Attenuated Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Measles Combined with Live Attenuated Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Measles Combined with Live Attenuated Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Measles Combined with Live Attenuated Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Merck, Beijing Institute of Biological Products Co., Ltd, Shanghai Institute of Biological Products Co., Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Measles Combined with Live Attenuated Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Liquid
Powder
Market segment by Application
Hospital
Clinic
Major players covered
GSK
Merck
Beijing Institute of Biological Products Co., Ltd
Shanghai Institute of Biological Products Co., Ltd
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Measles Combined with Live Attenuated Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Measles Combined with Live Attenuated Vaccine, with price, sales quantity, revenue, and global market share of Measles Combined with Live Attenuated Vaccine from 2020 to 2025.
Chapter 3, the Measles Combined with Live Attenuated Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Measles Combined with Live Attenuated Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Measles Combined with Live Attenuated Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Measles Combined with Live Attenuated Vaccine.
Chapter 14 and 15, to describe Measles Combined with Live Attenuated Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Measles Combined with Live Attenuated Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Liquid
- 1.3.3 Powder
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Measles Combined with Live Attenuated Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.5 Global Measles Combined with Live Attenuated Vaccine Market Size & Forecast
- 1.5.1 Global Measles Combined with Live Attenuated Vaccine Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Measles Combined with Live Attenuated Vaccine Sales Quantity (2020-2031)
- 1.5.3 Global Measles Combined with Live Attenuated Vaccine Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 GSK
- 2.1.1 GSK Details
- 2.1.2 GSK Major Business
- 2.1.3 GSK Measles Combined with Live Attenuated Vaccine Product and Services
- 2.1.4 GSK Measles Combined with Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 GSK Recent Developments/Updates
- 2.2 Merck
- 2.2.1 Merck Details
- 2.2.2 Merck Major Business
- 2.2.3 Merck Measles Combined with Live Attenuated Vaccine Product and Services
- 2.2.4 Merck Measles Combined with Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Merck Recent Developments/Updates
- 2.3 Beijing Institute of Biological Products Co., Ltd
- 2.3.1 Beijing Institute of Biological Products Co., Ltd Details
- 2.3.2 Beijing Institute of Biological Products Co., Ltd Major Business
- 2.3.3 Beijing Institute of Biological Products Co., Ltd Measles Combined with Live Attenuated Vaccine Product and Services
- 2.3.4 Beijing Institute of Biological Products Co., Ltd Measles Combined with Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
- 2.4 Shanghai Institute of Biological Products Co., Ltd
- 2.4.1 Shanghai Institute of Biological Products Co., Ltd Details
- 2.4.2 Shanghai Institute of Biological Products Co., Ltd Major Business
- 2.4.3 Shanghai Institute of Biological Products Co., Ltd Measles Combined with Live Attenuated Vaccine Product and Services
- 2.4.4 Shanghai Institute of Biological Products Co., Ltd Measles Combined with Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Shanghai Institute of Biological Products Co., Ltd Recent Developments/Updates
3 Competitive Environment: Measles Combined with Live Attenuated Vaccine by Manufacturer
- 3.1 Global Measles Combined with Live Attenuated Vaccine Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Measles Combined with Live Attenuated Vaccine Revenue by Manufacturer (2020-2025)
- 3.3 Global Measles Combined with Live Attenuated Vaccine Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Measles Combined with Live Attenuated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Measles Combined with Live Attenuated Vaccine Manufacturer Market Share in 2024
- 3.4.3 Top 6 Measles Combined with Live Attenuated Vaccine Manufacturer Market Share in 2024
- 3.5 Measles Combined with Live Attenuated Vaccine Market: Overall Company Footprint Analysis
- 3.5.1 Measles Combined with Live Attenuated Vaccine Market: Region Footprint
- 3.5.2 Measles Combined with Live Attenuated Vaccine Market: Company Product Type Footprint
- 3.5.3 Measles Combined with Live Attenuated Vaccine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Measles Combined with Live Attenuated Vaccine Market Size by Region
- 4.1.1 Global Measles Combined with Live Attenuated Vaccine Sales Quantity by Region (2020-2031)
- 4.1.2 Global Measles Combined with Live Attenuated Vaccine Consumption Value by Region (2020-2031)
- 4.1.3 Global Measles Combined with Live Attenuated Vaccine Average Price by Region (2020-2031)
- 4.2 North America Measles Combined with Live Attenuated Vaccine Consumption Value (2020-2031)
- 4.3 Europe Measles Combined with Live Attenuated Vaccine Consumption Value (2020-2031)
- 4.4 Asia-Pacific Measles Combined with Live Attenuated Vaccine Consumption Value (2020-2031)
- 4.5 South America Measles Combined with Live Attenuated Vaccine Consumption Value (2020-2031)
- 4.6 Middle East & Africa Measles Combined with Live Attenuated Vaccine Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Measles Combined with Live Attenuated Vaccine Sales Quantity by Type (2020-2031)
- 5.2 Global Measles Combined with Live Attenuated Vaccine Consumption Value by Type (2020-2031)
- 5.3 Global Measles Combined with Live Attenuated Vaccine Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Measles Combined with Live Attenuated Vaccine Sales Quantity by Application (2020-2031)
- 6.2 Global Measles Combined with Live Attenuated Vaccine Consumption Value by Application (2020-2031)
- 6.3 Global Measles Combined with Live Attenuated Vaccine Average Price by Application (2020-2031)
7 North America
- 7.1 North America Measles Combined with Live Attenuated Vaccine Sales Quantity by Type (2020-2031)
- 7.2 North America Measles Combined with Live Attenuated Vaccine Sales Quantity by Application (2020-2031)
- 7.3 North America Measles Combined with Live Attenuated Vaccine Market Size by Country
- 7.3.1 North America Measles Combined with Live Attenuated Vaccine Sales Quantity by Country (2020-2031)
- 7.3.2 North America Measles Combined with Live Attenuated Vaccine Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Measles Combined with Live Attenuated Vaccine Sales Quantity by Type (2020-2031)
- 8.2 Europe Measles Combined with Live Attenuated Vaccine Sales Quantity by Application (2020-2031)
- 8.3 Europe Measles Combined with Live Attenuated Vaccine Market Size by Country
- 8.3.1 Europe Measles Combined with Live Attenuated Vaccine Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Measles Combined with Live Attenuated Vaccine Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Measles Combined with Live Attenuated Vaccine Market Size by Region
- 9.3.1 Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Measles Combined with Live Attenuated Vaccine Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Measles Combined with Live Attenuated Vaccine Sales Quantity by Type (2020-2031)
- 10.2 South America Measles Combined with Live Attenuated Vaccine Sales Quantity by Application (2020-2031)
- 10.3 South America Measles Combined with Live Attenuated Vaccine Market Size by Country
- 10.3.1 South America Measles Combined with Live Attenuated Vaccine Sales Quantity by Country (2020-2031)
- 10.3.2 South America Measles Combined with Live Attenuated Vaccine Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Measles Combined with Live Attenuated Vaccine Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Measles Combined with Live Attenuated Vaccine Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Measles Combined with Live Attenuated Vaccine Market Size by Country
- 11.3.1 Middle East & Africa Measles Combined with Live Attenuated Vaccine Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Measles Combined with Live Attenuated Vaccine Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Measles Combined with Live Attenuated Vaccine Market Drivers
- 12.2 Measles Combined with Live Attenuated Vaccine Market Restraints
- 12.3 Measles Combined with Live Attenuated Vaccine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Measles Combined with Live Attenuated Vaccine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Measles Combined with Live Attenuated Vaccine
- 13.3 Measles Combined with Live Attenuated Vaccine Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Measles Combined with Live Attenuated Vaccine Typical Distributors
- 14.3 Measles Combined with Live Attenuated Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Measles Combined with Live Attenuated Vaccine. Industry analysis & Market Report on Measles Combined with Live Attenuated Vaccine is a syndicated market report, published as Global Measles Combined with Live Attenuated Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Measles Combined with Live Attenuated Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
